Waddell & Reed Financial’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$12.6M Sell
168,640
-941,262
-85% -$86.9M 0.03% 391
2020
Q4
$189M Sell
1,109,902
-19,088
-2% -$2.83M 0.4% 61
2020
Q3
$159M Sell
1,128,990
-2,443
-0.2% -$371K 0.38% 60
2020
Q2
$181M Sell
1,131,433
-870
-0.1% -$118K 0.47% 51
2020
Q1
$111M Sell
1,132,303
-3,668
-0.3% -$419K 0.36% 75
2019
Q4
$147M Sell
1,135,971
-51,155
-4% -$5.16M 0.36% 68
2019
Q3
$89.4M Buy
1,187,126
+131,544
+12% +$15.5M 0.23% 124
2019
Q2
$160M Buy
1,055,582
+723
+0.1% +$87.9K 0.4% 65
2019
Q1
$126M Sell
1,054,859
-129,286
-11% -$16.6M 0.31% 85
2018
Q4
$129M Buy
1,184,145
+240,510
+25% +$30.1M 0.37% 64
2018
Q3
$152M Buy
943,635
+159,235
+20% +$21.8M 0.34% 83
2018
Q2
$104M Buy
+784,400
New +$74M 0.24% 119

Other funds holding SRPT